One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...
Nvidia and other technology companies are propping up Wall Street on Monday, while most other stocks fall following a ...
9hon MSN
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Republicans had proposed extending government funding at current levels until Nov. 21 to allow for members to continue working on full-year appropriations bills. Democrats made a counteroffer to keep ...
President Donald Trump 's administration, citing the government shutdown, said Wednesday it was putting a hold on roughly $18 billion to fund a new rail tunnel beneath the Hudson River between New ...
George Tidmarsh’s short run directing the agency’s principal drug review office reportedly ended in controversy. Elsewhere, ...
Plus: OpenAI in USD38b deal with AWS to access Nvidia GPUs; Kimberly-Clark to buy Tylenol maker Kenvue at 46% premium; Animoca to list on Nasdaq via reverse merger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback